Showing results (341-350 of 639) with videos related to
Sort By:
Pageof 64
International Journal of Oncology|December 16, 2014
Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancerAkihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, et al.International Journal of Oncology|August 7, 2014
Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transitionAkihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, et al.Plos One|May 9, 2015
Extended RAS and BRAF Mutation Analysis Using Next-Generation SequencingKazuko Sakai, Junji Tsurutani, Takeharu Yamanaka, et al.Scientific Reports|August 9, 2017
PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastomaYoshihiro Otani, Joji Ishida, Kazuhiko Kurozumi, et al.International Journal of Oncology|October 18, 2016
MEK inhibitors against MET-amplified non-small cell lung cancerMasato Chiba, Yosuke Togashi, Shuta Tomida, et al.The Annals of Thoracic Surgery|April 27, 2010
Calcineurin inhibitor-related cholestasis complicating lung transplantationTakahiro Oto, Mikio Okazaki, Ken Takata, et al.Oncology Letters|December 2, 2015
Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinomaJunichi Soh, Shinichi Toyooka, Keitaro Matsuo, et al.International Journal of Cancer|October 2, 2003
Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokersSabine Zöchbauer-Müller, Stephen Lam, Shinichi Toyooka, et al.International Journal of Cancer|September 24, 2004
Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancersMasaaki Yano, Shinichi Toyooka, Kazunori Tsukuda, et al.Surgical Case Reports|September 17, 2021
Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibodyYasuaki Tomioka, Shinji Otani, Shin Tanaka, et al.Pageof 64